Concurrent Session Abstracts E: Cost-effectiveness Analysis: Applications

Tuesday, October 21, 2008: 11:30 AM
Grand Ballroom B/C (Hyatt Regency Penns Landing)
Session Chairs:
Ahmed M. Bayoumi, MD, MSc and Johanna L. Bosch, PhD
11:30 AM
HEALTH AND ECONOMIC IMPACT OF HPV VACCINATION ON CERVICAL CANCER SCREENING IN SPAIN: IMPLICATIONS ON THE CURRENT SCREENING PRACTICES OF VACCINATED COHORTS
Mireia Diaz-Sanchis, MSc1, Jane J. Kim, PhD2, Silvia de Sanjose, MD, PhD3, Elena Ferrer, MSc1, Laia Bruni, MD, MPH1, Jesse D. Ortendahl, BS2, F. Xavier Bosch, MD, PhD3 and Sue J. Goldie, MD, MPH2, (1)Catalan Institute of Oncology, Hospitalet de Llobregat, Spain, (2)Harvard School of Public Health, Boston, MA, (3)Catalan Institute of Oncology, Barcelona, Spain
11:45 AM
HEALTH ECONOMIC EVALUATION OF PRESSURE ULCER PREVENTION OPTIONS IN LONG-TERM CARE SETTINGS ACROSS ONTARIO, CANADA
Wendong Chen, MD1, Ba Pham, MSc1, Beate Sander, RN, MBA, MEcDev1, Anita Stern, PhD1, Ava John-Baptiste, MHSc1, Hla-Hla Thein, MD, MPH, PhD2, Márcio Machado, PhD1, Walter Wodchis, PhD1, Tara Gomes, MHSc3, Farah Farahati, PhD1, Nancy Sikich, MSc3, Ahmed Bayoumi, MD, MSc1 and Murray Krahn, MD, MSc1, (1)University of Toronto, Toronto, ON, Canada, (2)University of New South Wales, Sydney, Australia, (3)Medical Advisory Secretariat, Ontario Ministry of Health and Long-Term Care, Toronto, ON, Canada
12:00 PM
THE COST-EFFECTIVENESS OF ONTARIO'S UNIVERSAL INFLUENZA IMMUNIZATION PROGRAM
Beate Sander, RN, MBA, MEcDev1, Jeff Kwong, MD, MSc2, Chris T. Bauch, PhD3, Andreas Maetzel, MD, MSc, PhD4, Allison McGeer, MD5, Janet Raboud, PhD5 and Murray Krahn, MD, MSc1, (1)University of Toronto, Toronto, ON, Canada, (2)Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, (3)University of Guelph, Guelph, ON, Canada, (4)University Health Network, Toronto, ON, Canada, (5)Mount Sinai Hospital, Toronto, ON, Canada
12:15 PM
MODELING AND POLICY DEVELOPMENT: PSA SCREENING FOR PROSTATE CANCER
Ruth Etzioni, PhD1, Roman Gulati2, William Hazelton2 and Lurdes Inoue, PhD3, (1)Fred Hutchinson Cancer Research Center/ University of Washington, Seattle, WA, (2)Fred Hutchinson Cancer Research Center, Seattle, WA, (3)University of Washington, Seattle, WA
12:30 PM
MODELING COST EFFECTIVENESS OF ANTIVIRAL PROPHYLAXIS AND ADJUVANTED PRIME BOOST VACCINATION STRATEGIES FOR A POSSIBLE INFLUENZA PANDEMIC
Nayer Khazeni, MD, MS1, David W. Hutton, MS1, Alan Garber, MD, PhD2 and Douglas K. Owens, MD, MS3, (1)Stanford University, Stanford, CA, (2)Veterans Affairs Palo Alto Health Care System and Stanford University, Stanford, CA, (3)VA Palo Alto Health Care System & Stanford University, Palo Alto, CA
12:45 PM
MEDICARE BENEFICIARIES' STRENGTH OF PREFERENCE SCORES FOR ELECTIVE HEALTH CARE OPTIONS: ARE THEY TRAIT-LIKE OR STATE-LIKE?
R. Trafford Crump, M.P.A. and Hilary A. Llewellyn-Thomas, PhD, Dartmouth Medical School, Lebanon, NH